This special panel, part of the second day of Lunch With a Luminary talks, looks at the business side of the the booming science and engineering scene in Cambridge.
In 1960, the Kendall Square area bordering the MIT campus was a blighted wasteland of empty lots and outmoded warehouses and factories. Today it's home to the offices of international companies like Akamai, Amazon, Amgen, Apple, Biogen, EMC, Facebook, Genzyme, GlaxoSmithKline, Google, IBM, Johnson & Johnson, Microsoft, Novartis, Oracle, Pfizer, Philips, Sanofi, Schlumberger, VMware, and Yahoo, not to mention hundreds of smaller startups and investment firms.
How did this derelict district transform itself, in just 50 years, into the world's leading cluster of biotechnology and information technology research and innovation — surpassing even Silicon Valley in density? You'll hear answers to that question from four key contributors to Kendall Square's innovation culture, representing the the life sciences, the information technology industry, and the world of angel and venture investing. The session is designed for all science writers who want to understand the fundamental conditions for innovation and commercialization.
Maia Heymann, Senior managing director, CommonAngels
Scott McFadden, Senior program manager manager, Microsoft
Peter Parker, founder and director, LabCentral
Stephen Vinter, Site and engineering director, Google Cambridge